Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:dateCreated |
1975-10-8
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:issn |
0028-1298
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
287 Suppl
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
R95
|
pubmed:dateRevised |
2008-11-21
|
pubmed:meshHeading |
pubmed-meshheading:238156-Adrenergic beta-Antagonists,
pubmed-meshheading:238156-Blood Pressure,
pubmed-meshheading:238156-Cardiac Output,
pubmed-meshheading:238156-Depression, Chemical,
pubmed-meshheading:238156-Hemodynamics,
pubmed-meshheading:238156-Humans,
pubmed-meshheading:238156-Physical Exertion,
pubmed-meshheading:238156-Vascular Resistance
|
pubmed:year |
1975
|
pubmed:articleTitle |
Proceedings: Human pharmacological studies on the hemodynamic effects of a new beta-adrenergic antagonist (bufuralol-Hcl).
|
pubmed:publicationType |
Journal Article
|